Microbiology Testing Market Size, Revenue Growth Trends, Company Strategy Analysis Till 2027

 

Microbiology Testing Market

The global microbiology testing market is expecting a more than twofold rise from USD 2706.1 million in 2016 to USD 5409.1 million by 2023, reports Market Research Future (MRFR). The extensively studied report covers the drivers that are going to impact the market decidedly during the forecast period (2014-2023) and delivers a much-precise predictive analysis of the coming years of the market. Infectious diseases are on the rise, and several outbreaks of epidemics across the globe have spurred the demand for microbiology testing. Healthcare segment is witnessing a significant increase in expenditure all over the world, and an increase in research allotments are a positive sign for the microbiology testing market.

However, the market can witness a slight pullback caused by stringent regulatory frameworks, and patient reimbursement policies can impede the market growth for a short span of time. But the bottlenecked market can see a wider scope of possibility with improving technologies in the field of product enhancement which can ease the market growth considerably.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/697

Industry Trend:

The launch of Endozyme II Go by bioMerieux to test endotoxin in pharmaceutical grade water, injectable drugs, and other pharmaceutical products can be considered a remarkable step. This would also ensure easier and faster workflow than the previous models.

Becton, Dickinson, and Company (BD) has launched several diagnostic informatics and automation innovations to impact the microbiology testing market considerably. BD COR among them is an instrument to clinically measure women’s health, sexually transmitted infections and gastrointestinal applications. On the other hand, BD Kiestra ID/AST modules will use automation for bacterial identification and antibiotic susceptibility testing.

Segmentation:

The global microbiology testing market can be segmented by type, application, and end-users.

By type, the market can be segmented into instruments, chemicals & reagents, consumables & accessories, and others. Chemicals & reagents segment accounts for almost 42.1% of the global market

Application-based segmentation includes gastrointestinal infections, respiratory infections, urinary tract infections, sexually transmitted infections, and others. 

Based on end-users, the market can be segmented into hospital-based laboratory, independent laboratory, and academics & research institutes.

Regional Analysis:

Geographically, the market spans across regions namely North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

North America with 37.9% of the global share accounts for the maximum market share. Superior infrastructure, high amount of healthcare investment and a huge patient pool suffering from infectious diseases are pushing the market ahead, and the sector is equally trying to use innovation as the championing cause for further support.

The APAC is the second largest market and the fastest one as well. The market is expecting a stellar CAGR of 12.1% to drive them forward during the forecast period. Emerging economies from the region are spending remarkably to ensure an indelible impact on the market. Europe also is waiting to record significant growth rate during the review period. However, the MEA can fall behind the global average but will ensure a steady growth pace.

Market Dashboard:

The market is quite competitive as regional players are also giving the major market influencers steep competition. Strategies that have been employed by many include new launches just the way bioMerieux did and mergers and collaborations. For instance, Abbott has recently acquired Alere. Thermo Fisher Scientific Inc. on the other hand, has signed an agreement to acquire Gatan from Roper Technologies. 

Some of the prominent players in this market are Alere (US), BD (US), Beckman Coulter, Inc. (US), Biomérieux SA (France), Cepheid (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), and others.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/microbiology-testing-market-697

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com


Location: New York, NY, USA

Comments

Post a Comment

Popular posts from this blog

ICP-OES Spectrometer Industry Size, Share, Key Players, Growth Trend, and Forecast Till 2030

Image
  The global  ICP-OES Spectrometer Industry  was valued at USD 521.4 million in 2018 at a CAGR of 7.2% during the forecast period of 2019 to 2025. ICP-OES Spectrometer is an analytical instrument that is used for the detection of chemical elements. It uses the technique of inductively coupled plasma optical emission spectroscopy (ICP-OES) for carrying out its analysis procedure. Certain factors that propel the growth of the ICP-OES Spectrometer Industry include increasing R&D expenditure for the development of better analytical systems and growing technological advancements. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8120 However, the high cost of instruments and requirement of large capital investment for setting up instrument manufacturing plants is hindering the growth of the global ICP-OES Spectrometer Industry in the forecast period. Currently, the global ICP-OES Spectrometer Industry is dominated by several players. ...
Read more

Opioid Withdrawal Treatment Market Growth, Size Analysis, DROT, PEST, Porter’s, Region & Country Forecast Till 2030

Image
The global  opioid withdrawal treatment growth market held a market value of USD 1.8 billion in 2018 and is projected to grow at a CAGR of 10.1% over the forecast period. Opioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain. In some cases, usage of opioids causes addiction, and Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8123 Segmentation The global opioid withdrawal treatment market has been segmented into drug type and distribution channel. By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, a...
Read more

Preclinical Imaging Market Trends, Size, Key Factors, Major Players, Growth Strategies, Forecast Till 2027

Image
Preclinical Imaging Market Trends , Revenue Forecast, Competitive Landscape, Growth Factors, and Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) The global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period. Preclinical imaging solutions are used during the preclinical research for visualization of living animals. It is playing important role during drug development process. It is evaluating the effectiveness and safety of new treatments and describing drug distribution patterns before clinical use. preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging. Requ...
Read more